Abstract:Abstract The aim of this study is to design a novel pH and photothermal dual-responsive nanodrug delivery system with high biocompatibility and tumor targeting. Based on the high loading rate and good photothermal properties of graphene oxide (GO), we selected GO modified with chitosan (CO) and γ-polyglutamic acid (γ-PGA) as nanocarriers. CO and γ-PGA increased the dispersion of GO and improved the solubility of GO-CO-γ-PGA (G-C-P) in solution. To further improve the targeting of the system, the nucleic acid aptamer NH2-AS1411 (APT), which targets the nucleolin (C23), was attached to G-C-P and the targeted nano-delivery system APT-GO-CO-γ-PGA (A-G-C-P) was prepared by amidation. The synthesized samples were characterized using Fourier transform infrared spectroscopy (FTIR), Ultraviolet-visible spectrophotometer (UV-Vis), X-ray diffraction (XRD), Transmission electron microscopy (TEM), Dynamic light scattering (DLS) and Zeta potential, and their good biocompatibility and stable photothermal conversion properties were demonstrated experimentally. The nanocarrier can act as a photothermal agent, generating high temperatures to induce cell damage. The lower hemolysis rate reflects the good biocompatibility of the carrier. Doxorubicin hydrochloride (DOX) was selected as the model drug with a nanocarrier loading of 37.0 ± 0.74%, showing dual response drug release characteristics of pH and NIR light. The cytotoxicity and photothermal toxicity of the nanocarrier A-G-C-P and the drug delivery system APT-GO-CO-γ-PGA-DOX (A-G-C-P-D) on HeLa cells were investigated in cellular experiments. It was found that A-G-C-P had almost no toxic side effects on the cells, and the killing effect of A-G-C-P-D with the application of near-infrared light irradiation was more obvious, proving its good photothermal therapeutic effect, and further demonstrating that the combined effect of chemotherapy and photothermal treatment is significant than that of single treatment. Confocal microscopy and flow cytometry determined the distribution of DOX in the cells to different degrees after cell internalization. In vivo anti-tumor experiments were conducted to further investigate the therapeutic effects and safety of the targeted nano-drug delivery system in concert with photothermal. Compared with the weight loss and heart tissue damage caused by free DOX, A-G-C-P-D and NIR light irradiation did not cause any tissue damage and toxic side effects in nude mice, and have good biosafety; A-G-C-P-D and NIR light irradiation can inhibit tumor growth, cause damage to tumor tissue, significantly reduce Ki67 expression and increase Caspase-3 expression, all of which prove their good anti-tumor effects. This relatively non-invasive approach may provide a good direction for targeted drug delivery and chemotherapeutic photothermal treatment of tumors, greatly reducing the side effects of chemotherapy. The therapeutic effect of this nano-drug delivery system provides new ideas for clinical treatment strategies with potential applications and reference values, offering a broad prospect for biological applications.

Delivery of MutT Homolog 1 Inhibitor by Functionalized Graphene Oxide Nanoparticles for Enhanced Chemo-Photodynamic Therapy Triggers Cell Death in Osteosarcoma.

One-Pot Synthesized Nano-Heterostructure with Dual-Modal Catalytic ROS Generation Ability for High-Metastatic Orthotopic Osteosarcoma Therapy

Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma

Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy

Photothermally Reinforced Chemodynamic Therapy in the Treatment of Osteosarcoma by Polydopamine-Modified, Copper Peroxide Loaded ZIF8 Nanoparticles

Photodynamic-therapy and Chemotherapy of TPBC-PEG Nanoplatform Encapsulated Triptolide Synergistically Inhibit Primary Osteosarcoma Growth and Pulmonary Metastasis by Activating HIPPO Signaling

Platinum-based nanocomposites loaded with MTH1 inhibitor amplify oxidative damage for cancer therapy

Mitochondria targeted biomimetic platform for chemo/photodynamic combination therapy against osteosarcoma

Autophagy Inhibitor Enhance ZnPc/BSA Nanoparticle Induced Photodynamic Therapy by Suppressing PD-L1 Expression in Osteosarcoma Immunotherapy.

Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms

Polydopamine-modified ZIF-8 Nanoparticles As a Drug Carrier for Combined Chemo-Photothermal Osteosarcoma Therapy

Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy

Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy.

CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma

AS1411-targeted graphene oxide nano-drug delivery system for chemo-photothermal therapy of cervical cancer

A smart MnO2-doped graphene oxide nanosheet for enhanced chemo-photodynamic combinatorial therapy via simultaneous oxygenation and glutathione depletion

Intratumor delivery of amino-modified graphene oxide as a multifunctional photothermal agent for efficient antitumor phototherapy

A tri-responsive dual-drug delivery system based on mesoporous silica nanoparticles@polydopamine@graphene oxide nanosheets for chemo-photothermal therapy of osteosarcoma

Novel diketopyrrolopyrrole NIR-II fluorophores and DDR inhibitors for in vivo chemo-photodynamic therapy of osteosarcoma

PEGylated Mbpei-Rgo Nanocomposites Facilitate Hepotocarcinoma Treatment Combining Photothermal Therapy and Chemotherapy.

An Enzyme-responsive Porphyrin Metal-organic Framework Nanosystem for Targeted and Enhanced Synergistic Cancer Photo-chemo Therapy